The purpose of this application is to seek support of a multi- disciplinary Clinical Oncology Research Training Program. The Lombardi Cancer Center of Georgetown University (an NCI designated Comprehensive Cancer Center) is a unique resource for training academic physicians in all clinical and research disciplines associated with cancer care. This proposal describes a structure to support the research training of clinicians in areas of translational oncology research. A collaborative and comprehensive research training program is described between the principal clinical oncology disciplines( Medical Oncology, Surgical Oncology, Gynecologic Oncology, and Radiation Medicine) and the associated research disciplines (clinical trials and translational basic science). A mechanism is also outlined to identify, select and train promising clinical candidates in core areas of tumor biology, human oncology, clinical trials design and the ethical conduct of research. The training program will also provide an in-depth research training experience with an appropriate faculty mentor selected from either the clinical or basic science departments. Leadership for the program will be provided by the director of the Lombardi Cancer Center and the Director of the Medical Oncology fellowship program. The Advisory Board, which will supervise the selection and evaluation of the research candidates, comprises the senior leadership of the major oncology disciplines within Georgetown University as well as the Director of Biostatistics, the Associate Director for Cancer prevention and Control, the Director of Developmental Therapeutics and the Associate Director of Basic Science. Finally, a group of faculty of faculty preceptors has been identified to support this program, all with demonstrated success in translational oncology research as well as the training of new investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA076903-04
Application #
6173510
Study Section
Special Emphasis Panel (ZCA1-GRB-J (01))
Program Officer
Lei, Ming
Project Start
1997-09-30
Project End
2002-06-30
Budget Start
2000-09-19
Budget End
2001-06-30
Support Year
4
Fiscal Year
2000
Total Cost
$358,718
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Zandberg, Dan P; Liu, Sandy; Goloubeva, Olga et al. (2016) Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center. Head Neck 38:564-72
Zandberg, Dan P; Liu, Sandy; Goloubeva, Olga G et al. (2015) Emergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007. Cancer Prev Res (Phila) 8:12-9
Zandberg, Dan P; Rollins, Sandra; Goloubeva, Olga et al. (2015) A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN). Cancer Immunol Immunother 64:367-79
Zhang, Tianzheng; Wang, Ying; Zhang, Li et al. (2011) Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Gen Virol 92:181-7
Yang, Zhilong; Wen, Hui-Ju; Minhas, Veenu et al. (2009) The zinc finger DNA-binding domain of K-RBP plays an important role in regulating Kaposi's sarcoma-associated herpesvirus RTA-mediated gene expression. Virology 391:221-31
Bracho, F; van de Ven, C; Areman, E et al. (2003) A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCs. Cytotherapy 5:349-61
Salesiotis, Anastasios; Soong, Richie; Diasio, Robert B et al. (2003) Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinoma. Clin Cancer Res 9:580-5
Stearns, Vered; Singh, Baljit; Tsangaris, Theodore et al. (2003) A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Clin Cancer Res 9:124-33
Rudin, Charles M; Yang, Zejia; Schumaker, Lisa M et al. (2003) Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res 63:312-8
Ellis, Matthew; Davis, Natalie; Coop, Andrew et al. (2002) Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses. Clin Cancer Res 8:1155-66

Showing the most recent 10 out of 11 publications